US researchers found that patients who regularly took aspirin after being diagnosed with colorectal cancer had a reduced risk of dying from the disease, and the benefit was greater for patients with a type of colon cancer where the tumors overexpress the COX-2 enzyme, which happens in around two thirds of cases. However, more work needs to be done to confirm the result before applying it to patient care, said the researchers.